Global Varicella-Zoster Virus (VZV) Treatment Market Size, Status and Forecast 2021-2027

水痘帯状疱疹ウイルス(VZV)治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Varicella-Zoster Virus (VZV) Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR5863
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:93
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、水痘帯状疱疹ウイルス(VZV)治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(アシクロビル、バラシクロビル、ファムシクロビル、その他)、用途別市場規模(病院薬局、小売薬局、オンライン薬局)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・水痘帯状疱疹ウイルス(VZV)治療の市場動向
・企業の競争状況、市場シェア
・水痘帯状疱疹ウイルス(VZV)治療の種類別市場規模(アシクロビル、バラシクロビル、ファムシクロビル、その他)
・水痘帯状疱疹ウイルス(VZV)治療の用途別市場規模(病院薬局、小売薬局、オンライン薬局)
・水痘帯状疱疹ウイルス(VZV)治療の北米市場規模2016-2027(アメリカ、カナダ)
・水痘帯状疱疹ウイルス(VZV)治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・水痘帯状疱疹ウイルス(VZV)治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・水痘帯状疱疹ウイルス(VZV)治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・水痘帯状疱疹ウイルス(VZV)治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Roche、Merck、Pfizer、Novartis、Abbott、GlaxoSmithKline、Sanofi、Eli Lilly、Astrazeneca、Johnson & Johnson)
・結論

Market Analysis and Insights: Global Varicella-Zoster Virus (VZV) Treatment Market
The global Varicella-Zoster Virus (VZV) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Varicella-Zoster Virus (VZV) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Varicella-Zoster Virus (VZV) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Varicella-Zoster Virus (VZV) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Varicella-Zoster Virus (VZV) Treatment market.

Global Varicella-Zoster Virus (VZV) Treatment Scope and Market Size
Varicella-Zoster Virus (VZV) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Varicella-Zoster Virus (VZV) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Acyclovir
Valacyclovir
Famciclovir
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Sanofi
Eli Lilly
Astrazeneca

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acyclovir
1.2.3 Valacyclovir
1.2.4 Famciclovir
1.2.5 Others
1.3 Market by Application
1.3.1 Global Varicella-Zoster Virus (VZV) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Varicella-Zoster Virus (VZV) Treatment Market Perspective (2016-2027)
2.2 Varicella-Zoster Virus (VZV) Treatment Growth Trends by Regions
2.2.1 Varicella-Zoster Virus (VZV) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Varicella-Zoster Virus (VZV) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Varicella-Zoster Virus (VZV) Treatment Industry Dynamic
2.3.1 Varicella-Zoster Virus (VZV) Treatment Market Trends
2.3.2 Varicella-Zoster Virus (VZV) Treatment Market Drivers
2.3.3 Varicella-Zoster Virus (VZV) Treatment Market Challenges
2.3.4 Varicella-Zoster Virus (VZV) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Varicella-Zoster Virus (VZV) Treatment Players by Revenue
3.1.1 Global Top Varicella-Zoster Virus (VZV) Treatment Players by Revenue (2016-2021)
3.1.2 Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Varicella-Zoster Virus (VZV) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Varicella-Zoster Virus (VZV) Treatment Revenue
3.4 Global Varicella-Zoster Virus (VZV) Treatment Market Concentration Ratio
3.4.1 Global Varicella-Zoster Virus (VZV) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Varicella-Zoster Virus (VZV) Treatment Revenue in 2020
3.5 Varicella-Zoster Virus (VZV) Treatment Key Players Head office and Area Served
3.6 Key Players Varicella-Zoster Virus (VZV) Treatment Product Solution and Service
3.7 Date of Enter into Varicella-Zoster Virus (VZV) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Varicella-Zoster Virus (VZV) Treatment Breakdown Data by Type
4.1 Global Varicella-Zoster Virus (VZV) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Type (2022-2027)

5 Varicella-Zoster Virus (VZV) Treatment Breakdown Data by Application
5.1 Global Varicella-Zoster Virus (VZV) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027)
6.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type
6.2.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021)
6.2.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027)
6.2.3 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027)
6.3 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application
6.3.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021)
6.3.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027)
6.3.3 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027)
6.4 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country
6.4.1 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021)
6.4.2 North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027)
7.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type
7.2.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027)
7.3 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application
7.3.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027)
7.4 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country
7.4.1 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type
8.2.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application
8.3.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region
8.4.1 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027)
9.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type
9.2.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027)
9.3 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application
9.3.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027)
9.4 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country
9.4.1 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type
10.2.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application
10.3.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country
10.4.1 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Varicella-Zoster Virus (VZV) Treatment Introduction
11.1.4 Roche Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Varicella-Zoster Virus (VZV) Treatment Introduction
11.2.4 Merck Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Varicella-Zoster Virus (VZV) Treatment Introduction
11.3.4 Pfizer Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Varicella-Zoster Virus (VZV) Treatment Introduction
11.4.4 Novartis Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Varicella-Zoster Virus (VZV) Treatment Introduction
11.5.4 Abbott Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Varicella-Zoster Virus (VZV) Treatment Introduction
11.7.4 Sanofi Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Varicella-Zoster Virus (VZV) Treatment Introduction
11.8.4 Eli Lilly Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.8.5 Eli Lilly Recent Development
11.9 Astrazeneca
11.9.1 Astrazeneca Company Details
11.9.2 Astrazeneca Business Overview
11.9.3 Astrazeneca Varicella-Zoster Virus (VZV) Treatment Introduction
11.9.4 Astrazeneca Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.9.5 Astrazeneca Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Introduction
11.10.4 Johnson & Johnson Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acyclovir
Table 3. Key Players of Valacyclovir
Table 4. Key Players of Famciclovir
Table 5. Key Players of Others
Table 6. Global Varicella-Zoster Virus (VZV) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2016-2021)
Table 10. Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2022-2027)
Table 12. Varicella-Zoster Virus (VZV) Treatment Market Trends
Table 13. Varicella-Zoster Virus (VZV) Treatment Market Drivers
Table 14. Varicella-Zoster Virus (VZV) Treatment Market Challenges
Table 15. Varicella-Zoster Virus (VZV) Treatment Market Restraints
Table 16. Global Varicella-Zoster Virus (VZV) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Players (2016-2021)
Table 18. Global Top Varicella-Zoster Virus (VZV) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella-Zoster Virus (VZV) Treatment as of 2020)
Table 19. Ranking of Global Top Varicella-Zoster Virus (VZV) Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Varicella-Zoster Virus (VZV) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Varicella-Zoster Virus (VZV) Treatment Product Solution and Service
Table 23. Date of Enter into Varicella-Zoster Virus (VZV) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Varicella-Zoster Virus (VZV) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Varicella-Zoster Virus (VZV) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Varicella-Zoster Virus (VZV) Treatment Product
Table 66. Roche Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Varicella-Zoster Virus (VZV) Treatment Product
Table 71. Merck Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 72. Merck Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Varicella-Zoster Virus (VZV) Treatment Product
Table 76. Pfizer Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Varicella-Zoster Virus (VZV) Treatment Product
Table 81. Novartis Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Abbott Company Details
Table 84. Abbott Business Overview
Table 85. Abbott Varicella-Zoster Virus (VZV) Treatment Product
Table 86. Abbott Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 87. Abbott Recent Development
Table 88. GlaxoSmithKline Company Details
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Varicella-Zoster Virus (VZV) Treatment Product
Table 91. GlaxoSmithKline Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 92. GlaxoSmithKline Recent Development
Table 93. Sanofi Company Details
Table 94. Sanofi Business Overview
Table 95. Sanofi Varicella-Zoster Virus (VZV) Treatment Product
Table 96. Sanofi Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 97. Sanofi Recent Development
Table 98. Eli Lilly Company Details
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 101. Eli Lilly Recent Development
Table 102. Astrazeneca Company Details
Table 103. Astrazeneca Business Overview
Table 104. Astrazeneca Varicella-Zoster Virus (VZV) Treatment Product
Table 105. Astrazeneca Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 106. Astrazeneca Recent Development
Table 107. Johnson & Johnson Company Details
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Varicella-Zoster Virus (VZV) Treatment Product
Table 110. Johnson & Johnson Revenue in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021) & (US$ Million)
Table 111. Johnson & Johnson Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Acyclovir Features
Figure 3. Valacyclovir Features
Figure 4. Famciclovir Features
Figure 5. Others Features
Figure 6. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Varicella-Zoster Virus (VZV) Treatment Report Years Considered
Figure 11. Global Varicella-Zoster Virus (VZV) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Varicella-Zoster Virus (VZV) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Regions (2022-2027)
Figure 15. Global Varicella-Zoster Virus (VZV) Treatment Market Share by Players in 2020
Figure 16. Global Top Varicella-Zoster Virus (VZV) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella-Zoster Virus (VZV) Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Varicella-Zoster Virus (VZV) Treatment Revenue in 2020
Figure 18. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Varicella-Zoster Virus (VZV) Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027)
Figure 22. North America Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027)
Figure 23. North America Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027)
Figure 24. United States Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027)
Figure 28. Europe Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027)
Figure 29. Europe Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027)
Figure 30. Germany Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Varicella-Zoster Virus (VZV) Treatment Market Share by Region (2016-2027)
Figure 40. China Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Varicella-Zoster Virus (VZV) Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Varicella-Zoster Virus (VZV) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 63. Abbott Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 67. Astrazeneca Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 68. Johnson & Johnson Revenue Growth Rate in Varicella-Zoster Virus (VZV) Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[水痘帯状疱疹ウイルス(VZV)治療の世界市場規模・現状・予測2021年-2027年] (Global Varicella-Zoster Virus (VZV) Treatment Market Size, Status and Forecast 2021-2027 / QY21APR5863)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆